ym 529 has been researched along with Invasiveness, Neoplasm in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imano, M; Itoh, T; Nishida, S; Ogaki, M; Satou, T; Tsubaki, M; Yanae, M | 1 |
| Cui, N; Guo, C; Hashimoto, S; Noma, H; Nomura, T; Okamoto, M; Sato, M; Shibahala, T; Takagi, R; Yokoo, K; Yu, G | 1 |
| Keller, ET; Miwa, S; Mizokami, A; Namiki, M; Taichman, R; Zhang, J | 1 |
| Kubo, T; Matsuo, T; Ochi, M; Sakai, A; Shimose, S; Tanaka, K; Yasunaga, Y | 1 |
4 other study(ies) available for ym 529 and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Reduction of metastasis, cell invasion, and adhesion in mouse osteosarcoma by YM529/ONO-5920-induced blockade of the Ras/MEK/ERK and Ras/PI3K/Akt pathway.
Topics: Animals; Cell Adhesion; Cell Line, Tumor; Cell Movement; Diphosphonates; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Neoplastic; Imidazoles; Male; Matrix Metalloproteinases; Mice; Mice, Inbred C3H; Mitogen-Activated Protein Kinase Kinases; Neoplasm Invasiveness; Neoplasm Metastasis; Osteosarcoma; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; ras Proteins; RNA, Messenger | 2012 |
Effect of YM529 on a model of mandibular invasion by oral squamous cell carcinoma in mice.
Topics: Animals; Body Weight; Bone Resorption; Carcinoma, Squamous Cell; Carrier Proteins; Cell Line, Tumor; Diphosphonates; Disease Models, Animal; Gene Expression; Glycoproteins; Imaging, Three-Dimensional; Imidazoles; Interleukin-6; Male; Mandible; Membrane Glycoproteins; Mice; Mice, Inbred C3H; Mouth Neoplasms; Neoplasm Invasiveness; Osteoclasts; Osteoprotegerin; Parathyroid Hormone-Related Protein; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tomography, X-Ray Computed; Tumor Necrosis Factor-alpha | 2005 |
The bisphosphonate YM529 inhibits osteolytic and osteoblastic changes and CXCR-4-induced invasion in prostate cancer.
Topics: Animals; Bone Marrow; Bone Neoplasms; Cell Growth Processes; Cell Line, Tumor; Chemokine CXCL12; Chemokines, CXC; Diphosphonates; Humans; Imidazoles; Male; Mice; Mice, SCID; Neoplasm Invasiveness; Osteoblasts; Prostatic Neoplasms; Receptors, CXCR4; Xenograft Model Antitumor Assays | 2005 |
Inhibitory effects of a new bisphosphonate, minodronate, on proliferation and invasion of a variety of malignant bone tumor cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bone Density Conservation Agents; Bone Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Diphosphonates; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Imidazoles; Inhibitory Concentration 50; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Transplantation; Sarcoma; Transplantation, Heterologous; Xenograft Model Antitumor Assays | 2006 |